Waldmann Thomas A
Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Arthritis Res Ther. 2004;6(4):174-7. doi: 10.1186/ar1202. Epub 2004 Jun 22.
Interleukin (IL)-15 is a dangerous inflammatory cytokine that induces tumor-necrosis factor-alpha, IL-1beta and inflammatory chemokines. It inhibits self-tolerance mediated by IL-2 mediated activation-induced cell death and facilitates maintenance of CD8+ memory T-cell survival including that of self-directed memory cells. Disordered IL-15 expression has been reported in patients with an array of inflammatory autoimmune diseases. A series of therapeutic agents that inhibit IL-15 action have been introduced, including the soluble IL-15 receptor (IL-15R) alpha chain, mutant IL-15, and antibodies directed against the IL-15 cytokine and against the IL-2R/IL-15R beta subunit used by IL-2 and IL-15.
白细胞介素(IL)-15是一种危险的炎性细胞因子,可诱导肿瘤坏死因子-α、IL-1β和炎性趋化因子。它抑制由IL-2介导的活化诱导细胞死亡所介导的自身耐受性,并促进CD8+记忆T细胞存活的维持,包括自身导向记忆细胞的存活。据报道,一系列炎性自身免疫性疾病患者存在IL-15表达紊乱的情况。已经引入了一系列抑制IL-15作用的治疗药物,包括可溶性IL-15受体(IL-15R)α链、突变型IL-15,以及针对IL-15细胞因子和针对IL-2和IL-15所使用的IL-2R/IL-15Rβ亚基的抗体。